← Back to Search

Control for Tubal Ligation

N/A
Waitlist Available
Led By Kate' Pettit, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 weeks
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study is to evaluate the feasibility and safety of salpingectomy versus standard tubal ligation in women undergoing surgical sterilization at the time of a planned cesarean delivery. Salpingectomy is currently being investigated as a potential strategy for ovarian cancer prevention. While this procedure is currently performed during hysterectomies, its feasibility at the time of cesarean delivery is not well established. This randomized, prospective clinical trial will compare the two sterilization methods to demonstrate that salpingectomy compared with standard tubal ligation at the time of cesarean delivery will not result in increased operative time, blood loss or other complications. This study is necessary to promote salpingectomy as a standard sterilization method during cesarean deliveries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time of tubal ligation
Secondary study objectives
Estimated blood loss
Interventional procedure
Total procedure time
Other study objectives
Length of stay
Readmission rate
Reoperation rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Tubal sterilization will be performed by bilateral salpingectomy using a ligasure device at the time of cesarean section.
Group II: ControlExperimental Treatment1 Intervention
Tubal sterilization will be performed by standard tubal ligation, either Parkland or Pomeroy technique, at the time of cesarean section
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Salpingectomy
2011
Completed Phase 2
~670
Tubal ligation
2017
N/A
~10630

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,658 Total Patients Enrolled
Kate' Pettit, MDPrincipal InvestigatorUniversity of Virginia
~5 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top